Aggregate Clinical Regulatory And Sales Milestone Payment

No definition available.

Name:	dnli_AggregateClinicalRegulatoryAndSalesMilestonePayment
Namespace Prefix:	dnli_
Data Type:	xbrli:monetaryItemType
Balance Type:	debit
Period Type:	instant

- Definition

Clinical And Regulatory Milestone Payment

+ References

No definition available.

+ Details

Name:	dnli_ClinicalAndRegulatoryMilestonePayment
Namespace Prefix:	dnli_
Data Type:	xbrli:monetaryItemType
Balance Type:	debit
Period Type:	instant

- Definition

Clinical, Regulatory, and Commercial Milestone Payment

+ References

No definition available.

+ Details

Name:	dnli_ClinicalRegulatoryAndCommercialMilestonePayment
Namespace Prefix:	dnli_
Data Type:	xbrli:monetaryItemType
Balance Type:	debit
Period Type:	instant

- Definition

Collaboration Agreement, Transaction Price, Increase

+ References

No definition available.

+ Details

Name:	dnli_CollaborationAgreementTransactionPriceIncrease
Namespace Prefix:	dnli_
Data Type:	xbrli:monetaryItemType
Balance Type:	credit
Period Type:	duration

- Definition

Collaborative Agreement, Funded Percentage

+ References

No definition available.

+ Details

Name:	dnli_CollaborativeAgreementFundedPercentage
Namespace Prefix:	dnli_
Data Type:	num:percentItemType
Balance Type:	na
Period Type:	instant

- Definition

Commercial Milestone Payments

+ References

No definition available.

+ Details

Name:	dnli_CommercialMilestonePayments
Namespace Prefix:	dnli_
Data Type:	xbrli:monetaryItemType
Balance Type:	credit
Period Type:	instant

- Definition

Number Of Indications

+ References

No definition available.

+ Details

Name:	dnli_NumberOfIndications
Namespace Prefix:	dnli_
Data Type:	xbrli:integerItemType
Balance Type:	na
Period Type:	instant

- Definition

Proceeds For Clinical Milestone

+ References

No definition available.

+ Details

Name:	dnli_ProceedsForClinicalMilestone
Namespace Prefix:	dnli_
Data Type:	xbrli:monetaryItemType
Balance Type:	debit
Period Type:	duration

- Definition

Regulatory Milestone Payment

+ References

No definition available.

+ Details

Name:	dnli_RegulatoryMilestonePayment
Namespace Prefix:	dnli_
Data Type:	xbrli:monetaryItemType
Balance Type:	credit
Period Type:	instant

- Definition

Upfront payments.

+ References

No definition available.

+ Details

Name:	dnli_UpfrontPayments
Namespace Prefix:	dnli_
Data Type:	xbrli:monetaryItemType
Balance Type:	debit
Period Type:	duration

- Definition

Amount, after allowance for credit loss, of right to consideration from customer for product sold and service rendered in normal course of business.

+ References

Reference 1: http://www.xbrl.org/2003/role/disclosureRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 210
-SubTopic 10
-Section S99
-Paragraph 1
-Subparagraph (SX 210.5-02(3))
-URI http://asc.fasb.org/extlink&oid=6877327&loc=d3e13212-122682

Reference 2: http://www.xbrl.org/2003/role/disclosureRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 944
-SubTopic 210
-Section S99
-Paragraph 1
-Subparagraph (SX 210.7-03(5))
-URI http://asc.fasb.org/extlink&oid=119400593&loc=d3e572229-122910

+ Details

Name:	us-gaap_AccountsReceivableNet
Namespace Prefix:	us-gaap_
Data Type:	xbrli:monetaryItemType
Balance Type:	debit
Period Type:	instant

- Definition

Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.

+ References

No definition available.

+ Details

Name:	us-gaap_CollaborativeArrangementsAndNoncollaborativeArrangementTransactionsLineItems
Namespace Prefix:	us-gaap_
Data Type:	xbrli:stringItemType
Balance Type:	na
Period Type:	duration

- Definition

Amount, excluding tax collected from customer, of revenue from satisfaction of performance obligation by transferring promised good or service to customer. Tax collected from customer is tax assessed by governmental authority that is both imposed on and concurrent with specific revenue-producing transaction, including, but not limited to, sales, use, value added and excise.

+ References

Reference 1: http://www.xbrl.org/2003/role/disclosureRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 606
-SubTopic 10
-Section 50
-Paragraph 4
-Subparagraph (a)
-URI http://asc.fasb.org/extlink&oid=118956577&loc=SL49130543-203045

Reference 2: http://www.xbrl.org/2003/role/disclosureRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 606
-SubTopic 10
-Section 50
-Paragraph 5
-URI http://asc.fasb.org/extlink&oid=118956577&loc=SL49130545-203045

+ Details

Name:	us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax
Namespace Prefix:	us-gaap_
Data Type:	xbrli:monetaryItemType
Balance Type:	credit
Period Type:	duration

- Details

Name:	us-gaap_TypeOfArrangementAxis=us-gaap_CollaborativeArrangementMember
Namespace Prefix:
Data Type:	na
Balance Type:
Period Type:

- Details

Name:	srt_CounterpartyNameAxis=dnli_SanofiMember
Namespace Prefix:
Data Type:	na
Balance Type:
Period Type:

- Details

Name:	srt_ProductOrServiceAxis=dnli_RetainedActivitiesMember
Namespace Prefix:
Data Type:	na
Balance Type:
Period Type:

- Details

Name:	srt_ProductOrServiceAxis=dnli_CNSProductMember
Namespace Prefix:
Data Type:	na
Balance Type:
Period Type:

- Details

Name:	srt_ProductOrServiceAxis=dnli_PeripheralProductMember
Namespace Prefix:
Data Type:	na
Balance Type:
Period Type:

- Details

Name:	srt_ProductOrServiceAxis=us-gaap_ProductMember
Namespace Prefix:
Data Type:	na
Balance Type:
Period Type:

- Details

Name:	srt_ProductOrServiceAxis=dnli_MilestoneTriggeredMember
Namespace Prefix:
Data Type:	na
Balance Type:
Period Type:

- Details

Name:	srt_CounterpartyNameAxis=dnli_DenaliMember
Namespace Prefix:
Data Type:	na
Balance Type:
Period Type:

Collaboration Agreements - Sanofi (Details) $ in Thousands		1 Months Ended	3 Months Ended								12 Months Ended			15 Months Ended
Collaboration Agreements - Sanofi (Details) $ in Thousands	Nov. 20, 2018 USD ($)	Aug. 31, 2019 USD ($)	Dec. 31, 2019 USD ($)	Sep. 30, 2019 USD ($)	Jun. 30, 2019 USD ($)	Mar. 31, 2019 USD ($)	Dec. 31, 2018 USD ($)	Sep. 30, 2018 USD ($)	Jun. 30, 2018 USD ($)	Mar. 31, 2018 USD ($)	Dec. 31, 2019 USD ($)	Dec. 31, 2018 USD ($)	Dec. 31, 2017 USD ($)	Dec. 31, 2019 USD ($)	Oct. 31, 2018 indication	Oct. 29, 2018
Collaborative Arrangements and Non-collaborative Arrangement Transactions [Line Items]
Number of indications \| indication															3
Milestones recognized			$ 4,672	$ 13,604	$ 4,197	$ 4,205	$ 125,676	$ 1,195	$ 1,648	$ 641	$ 26,678	$ 129,160	$ 0
Collaborative Arrangement \| Sanofi
Collaborative Arrangements and Non-collaborative Arrangement Transactions [Line Items]
Upfront payment	$ 125,000
Milestone payments upon achievement of certain clinical, regulatory and sales milestone events	1,100,000
Funded percentage																70.00%
Receivable			$ 1,200				$ 2,300				1,200	2,300		$ 1,200
Transaction price increase											20,400	2,300
Proceeds for milestone		$ 10,000										0
Milestones recognized											10,000
Collaborative Arrangement \| Sanofi \| Retained Activities
Collaborative Arrangements and Non-collaborative Arrangement Transactions [Line Items]
Transaction price increase											$ 10,400	$ 2,300
Collaborative Arrangement \| Sanofi \| CNS Product
Collaborative Arrangements and Non-collaborative Arrangement Transactions [Line Items]
Clinical and regulatory milestone payments	215,000
Regulatory milestone payment	385,000
Collaborative Arrangement \| Sanofi \| Peripheral Product
Collaborative Arrangements and Non-collaborative Arrangement Transactions [Line Items]
Regulatory milestone payment	175,000
Clinical, regulatory and commercial milestone payments	120,000
Commercial milestone payments	$ 200,000
Collaborative Arrangement \| Sanofi \| Product
Collaborative Arrangements and Non-collaborative Arrangement Transactions [Line Items]
Milestones recognized														0
Collaborative Arrangement \| Sanofi \| Milestone Triggered
Collaborative Arrangements and Non-collaborative Arrangement Transactions [Line Items]
Transaction price increase														$ 10,000
Collaborative Arrangement \| Denali
Collaborative Arrangements and Non-collaborative Arrangement Transactions [Line Items]
Funded percentage																30.00%